NUVB
NYSE · Pharmaceuticals
Nuvation Bio Inc
$4.16
-0.03 (-0.72%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+938.9% upside
Low Target
$30.63
Average Target
$43.22
High Target
$69.64
Current Price
$4.16
Current
$4.16
$4.16
Target
$43.22
$43.22
$30.63
$43.22 avg
$69.64
Scenario Analysis
Bear Case
$30.63
636.3%
Low target
Base Case
$43.22
+938.9%
Avg target
Bull Case
$69.64
+1,574.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.75
-57.3% from high
52-Week Low
$4.05
+2.8% from low
Target vs 52W High
$43.22
+343.3% vs high
Next Earnings Report
Nov 11, 2026
2d
until earnings
EPS Est: $-0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals